Stent Implantation Found Preferable for Previously Untreated Non-Complex Coronary Artery Disease
By HospiMedica International staff writers Posted on 03 Sep 2024 |

Millions of individuals worldwide undergo percutaneous coronary intervention (PCI) each year, a non-surgical technique to clear blockages in coronary arteries, which supply blood to the heart. Traditionally, coronary artery disease (CAD) is treated using balloon angioplasty, where a deflated balloon on a catheter is guided into a narrowed artery, inflated to open the vessel, and followed by placing a drug-eluting stent (DES) to keep the artery open and reduce the risk of restenosis—the re-narrowing of the artery. While effective, 2% of patients experience in-stent restenosis annually, which can lead to complications due to the stent's permanent presence that can interfere with the artery's natural functions and promote inflammation. This has led to interest in stent-free options like drug-coated balloons (DCB), which have proven as effective as DES in treating small vessel CAD (diameter ≤ 3.0 mm), though questions remain about their long-term efficacy and safety in treating broader coronary artery conditions.
In a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing PCI, researchers from Xijing Hospital (Xi'an, China) discovered that DCBs did not perform as well as expected against second-generation DES. The RECCAGEFREE I trial, a randomized, non-inferiority trial, enrolled PCI patients with previously untreated, non-complex CAD from 43 sites across China between February 2021 and May 2022. Patients were randomly assigned to either DCB angioplasty with potential rescue stenting (1,133 patients) or to receive a thin-strut sirolimus-eluting stent (1,139 patients). Overall, 9% (106/1,133) of DCB patients required rescue DES placement following unsatisfactory angioplasty results.
At the two-year mark, the primary endpoint—combined rates of cardiac death, target vessel myocardial infarction, and clinically or physiologically necessary target lesion revascularization (Device-Oriented Composite Endpoint [DoCE])—was 6.4% for DCBs and 3.4% for DES, with an absolute risk difference of 3.04%, exceeding the pre-set threshold of 2.68% for non-inferiority. This discrepancy was primarily due to higher rates of revascularization required with DCBs (3.1% vs 1.2%). However, subgroup analysis indicated significant variation in outcomes based on vessel diameter, warranting further research. While DES was preferable for larger vessel disease (diameter > 3.0 mm), in small vessel disease (≤3.0 mm), encompassing over 1,000 patients, DCB and DES showed similar rates of DoCE over two years, highlighting the need for more targeted studies to confirm these findings.
“Drug-coated balloon angioplasty failed to achieve noninferiority compared to standard treatment with second-generation thin strut drug-eluting stents, mainly due to the need for more repeat procedures (revascularization),” said senior author Dr. Ling Tao from Xijing Hospital. “Our results show that the attempted strategy of “leave nothing behind” by using paclitaxel-coated balloons in de novo non-complex coronary artery disease was disproven, and DES implantation should continue to be the standard of care for these patients.”
Related Links:
Xijing Hospital
Latest Surgical Techniques News
- Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
- Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
- Spectroscopy Technique Improves Surgery for Pediatric Epilepsy Patients
- Bioengineered Arteries Show Promise for Cardiovascular Surgery
- Online Tool Guides Surgical Decisions for Gallbladder Cancer
- Innovative Technology Enables Rapid Life-Saving Surgical Leak Detection
- First-Of-Its-Kind Bioresorbable Implant to Help Children with Rare Respiratory Disease
- Screw-Shaped Magnetic Microrobots to Transform Treatment for Patients with Inoperable Blood Clots
- "Ultra-Rapid" Testing in the OR Could Enable Accurate Removal of Brain Tumors
- Automated Endoscopic Device Obtains Improved Biopsy Results in Single Pass
- World's First Machine Learning Model Combats Wrong-Site Surgery
- Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk
- New Surface Coating Could Prevent Blood Clotting in Medical Devices and Implants
- Dumbbell-Shaped Thrombectomy Device Offers Novel Approach to Cerebral Venous Sinus Thrombosis Treatment
- Novel Catheter Mimics Snake Teeth to Grab Blood Clots
- New Laparoscopic Imaging Technique Accurately Maps Biological Tissue for Minimally Invasive Surgery
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
Novel Coating Significantly Extends Longevity of Implantable Biosensors
Wearable and implantable biosensors capable of accurately detecting biological molecules in a non-invasive or minimally invasive way offer enormous potential for monitoring patients’ health and their responses... Read more
Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
Urinary tract infections (UTIs) are not only widespread and costly but also highly debilitating, significantly impacting the quality of life for those affected. The antibiotics commonly used to treat UTIs... Read more
New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
Preventable medication errors affect around 500,000 hospitalized patients in the U.S. every year. A significant portion of these errors occur with intravenous (IV) smart pumps, which require a precise... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more